Delivery Order SPE2DE24D0026-SPE2D626F38BY
- Not listed
- Henry Schein, Inc.'s USDG Federal Division was awarded a delivery order valued at $1,408.95 on January 13, 2026, for the supply of Marcaine 0.5% with epinephrine in 1.7 mL injectable form. This fixed-price contract with economic price adjustment provisions will be performed at the company's facility in Huntington Station, New York, with an ultimate completion date of January 16, 2026. The contract was awarded by the Defense Logistics Agency's Medical Supply Chain organization with no set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order to Henry Schein, Inc.'s USDG Federal Division on August 21, 2025, for the supply of Marcaine 0.5% with epinephrine in 1.7 mL injectable form. This fixed-price delivery order, valued at $1,059.01 with economic price adjustment provisions, is scheduled for completion by August 26, 2025, and will be performed at the contractor's location in Huntington Station, New York. No set-aside designation was utilized for this...
- Henry Schein, Inc.'s USDG Federal Division was awarded a $2,801.60 delivery order by the Defense Logistics Agency's Medical Supply Chain organization on January 15, 2026, for Marcaine 0.5% with epinephrine 1.7 ml injections. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of January 30, 2026, and will be performed at the contractor's facility in Huntington Station, New York. The award was made without set-aside designation under full and open...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,262.15 delivery order to Henry Schein, Inc. (USDG Federal Division) on December 17, 2025, for the supply of Marcaine 0.5% with Epinephrine 1.7 mL injectable pharmaceutical product. The contract utilizes a fixed-price structure with economic price adjustment provisions and carries an ultimate completion date of December 22, 2025. Performance will be executed at Henry Schein's facility in Huntington Station, New York. This delivery...
- Henry Schein, Inc.'s USDG Federal Division received a delivery order valued at $1,578.08 for Marcaine 0.5% with epinephrine 1.7 mL injectable pharmaceutical product, with an ultimate completion date of November 18, 2025. Awarded on November 3, 2025, by the Defense Logistics Agency's Medical Supply Chain organization, this fixed-price contract with economic price adjustment provisions carries no set-aside designation and was awarded through full and open competition. The place of performance is...
- This federal contract award is for the delivery of MARCAINE 0.5% W/ EPINEPHRINE medical supplies, awarded to Henry Schein, Inc. The $2,640.95 fixed-price contract with economic price adjustment was issued by the Defense Logistics Agency (DLA), a civilian agency that supports the Department of Defense. The contract has an ultimate completion date of November 5, 2021 and does not utilize any set-aside designations, indicating full and open competition. Henry Schein, Inc. is a large,...
- This federal contract award was issued by the Medical Supply Chain division of the Defense agency to Henry Schein, Inc., a global medical and dental supply distributor. The $1,011.40 Delivery Order contract is for the delivery of MARCAINE 0.5% W/EPI 1.7 ML INJ, a local anesthetic injection, with a period of performance ending on August 26, 2024. The contract was awarded on a fixed-price with economic price adjustment basis and does not have a set-aside designation, indicating open competition....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a global medical and dental supply distributor. The contract is for the delivery of MARCAINE 0.5% W/EPI 1.7 ML INJ, a local anesthetic product, with a fixed price and economic price adjustment. The contract has a ceiling value of $2,631.23 and an ultimate completion date of April 28, 2025. Henry Schein, Inc. operates under its Usdg Federal Division to serve various government healthcare...
- This federal contract award, valued at $4,227.75, was issued by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a global distributor of medical and dental supplies. The contract is a delivery order for the supply of Marcaine 0.5% with Epinephrine 1.7 mL injectable medication. This award does not have a set-aside designation, indicating it was awarded through full and open competition. Henry Schein, through its Enterprise Health/Federal Sales Division, has established itself as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a global distributor of medical and dental supplies, for the delivery of MARCAINE 0.5% W/EPI 1.7 ML INJ (SPE2DE24D0026|SPE2D624F6ST0). The $1,007.82 fixed-price with economic price adjustment contract has an ultimate completion date of August 5, 2024. Henry Schein's Enterprise Health / Federal Sales Division, which focuses on serving federal government agencies, will be fulfilling this order. The...
- SPE2DE24D0026Indefinite Delivery Contract
- SPE2DE24D0026-SPE2D626F38BYDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,343.70 to Henry Schein, Inc.'s USDG Federal Division for 0.5% Marcaine with epinephrine in 1.7 mL injectable formulation. The contract, executed on January 30, 2026, with an ultimate completion date of February 4, 2026, utilizes a fixed-price structure with economic price adjustment provisions and involves no set-aside designation. Performance will occur at Henry Schein's facility in Melville, New York. This delivery order is issued under Henry Schein's larger $30 million indefinite delivery contract (contract number 4610117412) with DLA Troop Support Medical, awarded April 23, 2025, and operating through the Electronic Catalog (ECAT) program through April 22, 2030. Henry Schein, Inc. is a Fortune 500 global medical and dental supply distributor serving as a critical vendor across multiple federal agencies, including the Department of Defense, Veterans Affairs, and Federal Bureau of Prisons network. The company's extensive federal portfolio encompasses medical equipment, dental instruments, laboratory supplies, pharmaceuticals, and infection control materials. The Marcaine injectable represents a typical pharmaceutical product within the company's comprehensive supply offerings to federal healthcare facilities and military medical operations. No set-aside designation was applied to this award, reflecting procurement through full and open competition methodologies consistent with Henry Schein's established federal contracting practices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/29/26 |